Open AccessImpact myocardial cytoprotection and inotropic stimulation at the annual prognosis in patients with myocardial infarction lifting segment ST, complicated heart failure
Author(s) -
М. Н. Синькова,
Синькова Маргарита Николаевна,
Л. К. Исаков,
Исаков Леонид Константинович,
T. V Pepelyaeva,
Пепеляева Татьяна Васильевна,
Н. И. Тарасов,
Тарасов Николай Иванович,
A. T. Teplyakov,
Тепляков Александр Трофимович,
F. Yu Mukharlyamov,
Мухарлямов Федор Юрьевич
Publication year - 2015
Publication title -
cardiosomatika
Language(s) - English
Resource type - Journals
eISSN - 2658-5707
pISSN - 2221-7185
DOI - 10.26442/cs45131
Subject(s) - medicine , cardiology , levosimendan , inotrope , myocardial infarction , heart failure , percutaneous transluminal coronary angioplasty
The article analyzes the effectiveness and safety of treatment cytoprotectant meldonium dihydrate and inotropic stimulator of levosimendan on an annual prognosis in patients with myocardial infarction complicated by acute heart failure II-III class Killip, subjected to percutaneous transluminal coronary angioplasty.